J2KBIO Co., Ltd. (KOSDAQ: A420570)
Health Care · Biotechnology · KR
₩8,700.00
-8.52% today · -3.8% 1Y
J2KBIO Co., Ltd. (KOSDAQ: A420570) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.16M.
Over the last twelve months the share price has lost 3.8%, trading between 6.71K and 12.86K.
Tweenvest scores J2KBIO Co., Ltd. across four factors: quality 76/100, value 60/100, growth 67/100, dividend 66/100. Its strongest factor is quality.
A420570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.16M
- Revenue (TTM)
- $28.35M
- P/E
- 8.75
- EPS
- 994.22
- Dividend yield
- 2.87%
- Beta (5Y)
- 0.33
- 52-week high
- ₩12,860.00
- 52-week low
- ₩6,710.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.85M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Instil Bio, Inc.NasdaqCM: TIL | $40.08M | $5.91 | -12.31% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $38.71M | NT$15.70 | -3.68% |
| ME Therapeutics Holdings Inc.CNSX: METX | $38.53M | CA$1.80 | -35.71% |
| TMS Co., Ltd.TSE: 4891 | $38.44M | ¥132.00 | +0.76% |
| eXoZymes, Inc.NasdaqCM: EXOZ | $37.96M | $4.09 | -22.10% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $37.83M | ¥43.00 | -4.44% |
| Sprint Bioscience AB (publ)OM: SPRINT | $37.82M | Skr3.55 | -2.74% |
| Novacyt S.A.ENXTPA: ALNOV | $37.63M | €0.46 | +1.20% |
Figures last refreshed Oct 18, 2026.